Christina Jewett

The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like...

With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.

Key drugs have been in scarce supply, revealing a deep crisis in the generic drug industry.

Lawmakers, U.S. officials and industry experts have offered measures to try to shore up the generic drug market.

The annual tobacco use survey given to middle and high school students revealed a decrease among older teenagers for the first time in several years.

The F.D.A. has approved many new programs that use artificial intelligence, but doctors are skeptical that the tools really improve care or are backed by...

Some vapes are appearing with increasing nicotine levels that approach those in a carton of cigarettes. U.S. regulators did not authorize them, but have failed...

Genetic testing that reveals potential cancer risks or other maladies with no regulatory oversight is among the targets of the agency’s proposed review.

Pharmacists affiliated with the University of Florida have spent decades nudging the agency to pull a decongestant from over-the-counter medicines.

The agency now must decide whether products containing the ingredient, like some Sudafed and NyQuil products, should no longer be sold.